Share The Wealth by Chris Gupta
January 21, 2004

Public is being regularly deceived by the drug s.


..."The public is being regularly deceived and exploited."... So what else is new like they say buyer be aware! Unfortunately, most fall for these tricks, hopefully, this information will help set the record straight so fewer will fall for these shenanigans...

Chris Gupta

Foregone conclusions

The public is being regularly deceived by the drug trials funded by pharmaceutical companies, loaded to generate the results they need

Richard Smith Wednesday January 14, 2004 The Guardian

Drug companies spend hundreds of millions of pounds to bring a new drug to market, and tens of millions of pounds to do the clinical trials that are necessary for both registration and marketing. Understandably, they would prefer not to get results from these trials that are unfavourable to their drug. And, despite the ubiquitous uncertainties of science and medicine, they rarely do. How do they manage it?

In 1994, Canadian researchers looked at 69 trials of anti-arthritis drugs funded by drug companies and published in prominent medical journals. In every case the drug made by the company was as good as the comparative treatment, and in a quarter of the trials it was better. Not once did a company fund a trial that proved unfavourable to it.

Yet the whole scientific point of doing such trials is to answer so far unanswered questions. Supposedly, researchers conduct trials when they are in a charmed state called "equipoise", which means they are genuinely uncertain which is the best treatment. If they think one treatment is better than another, then they shouldn't be conducting the trial.

A review published in 2003 found 30 studies that had compared the results of trials funded by drug companies with those funded from other sources. Trials funded by companies were four times more likely to have results favourable to them than those funded by others.

Yet the technical quality of the trials funded by drug companies was always as good and often better than the quality of those funded by other sources. This is not surprising, as drug company trials are tightly regulated. There are explicit high standards, and companies can afford to hire the best to conduct the trials.

How then do companies usually manage to fund research that is favourable to them? An answer is supplied in a recent issue of the BMJ by Dave Sackett and Andy Oxman, two tireless campaigners for the better use of scientific evidence in medicine. They have founded a spoof company called Harlot - which stands for How to Achieve positive Results without actually Lying to Overcome the Truth. They created the company after it finally dawned on them that "being good and being poor are causally related: being good doesn't pay".

Harlot plc promises to give drug companies and others the results they want. Your drug may be wholly ineffective, Sackett and Oxman promise, but as long as it isn't a lot worse than a sip of triple distilled water, then Harlot can produce positive results from a trial. Importantly, these results are not usually achieved by doing poor quality trials. The trick is in the question asked and the design of the trial. Sackett and Oxman, both experts on the design and analysis of trials, describe 13 methods for getting the results you want.

One of the commonest methods is to test a new drug not against an effective treatment but against a placebo. Ironically, regulators often require companies to do this. But what matters to patients is not whether a company's drug is better than nothing, but whether it is better than established treatments. Companies are nervous about these "head-to-head" trials, particularly if many drugs are being tested - because there may be only one winner and many losers. A huge publicly funded head-to-head trial of treatments for high blood pressure was published recently and threw companies into a tizz because it showed that long-established drugs that are off patent were better than newer, much more expensive drugs.

A company gets huge benefit from showing that its drug is better than a competitor's. But the company needs to control the trial, and Harlot suggests that a company compares its product with an inadequate dose of a competitor's product. This may have been the reason why previous trials on drugs for high blood pressure suggested that newer drugs were better.

A variant on this technique is to compare the drug with an excessive dose of the competitor's product: it is then possible to show that the company's drug has far fewer side-effects (because side-effects are more common with higher doses of a drug). This may have been the method for showing that new and expensive drugs for schizophrenia have fewer side-effects than older drugs.

Perhaps the most common method to avoid unfavourable results is to make sure that a trial is not big enough to show that a competitor product is either better or worse. Such trials are very common, and Silvio Garattini, a leading Italian researcher and critic of the drug industry, has proposed a consent form for them: "I understand that this trial is worthless for science and medicine, but will be of great use to the marketing department of Shangri-la Pharmaceuticals."

All this matters greatly because 70% of trials in major medical journals are funded by the drug industry. Often companies will buy reprints of these articles to use in promoting their drug. Sometimes they may spend up to £750,000.

Virtually all research on drugs is funded by the industry, because governments have taken the view that public money can be better spent elsewhere. The end result is that information on drugs (on which Britain spends £7bn a year) is distorted.

The Harlot article was written to amuse, but is as deadly serious as anything else published in the BMJ in the past 10 years. The public is being regularly deceived and exploited.

· Richard Smith is the editor of the British Medical Journal

rsmith@bmj.com

Guardian Unlimited © Guardian Newspapers Limited 2004

 


posted by Chris Gupta on Wednesday January 21 2004
updated on Saturday September 24 2005

URL of this article:
http://www.newmediaexplorer.org/chris/2004/01/21/public_is_being_regularly_deceived_by_the_drug_s.htm

 

 


Related Articles

Drinking Water Fluoridation is Genotoxic & Teratogenic
This paper by Prof. Joe Cummins is a very important 5 minute delegation made to London Ontario Canada "Civic Works Committee" public participation meeting on January 25, 2012 on fluoride*. While a bit technical it is short and easy to grasp. A must read as it goes to the heart of the matter regarding the well established toxicity of fluoride which is well in all scientific circles even before water... [read more]
February 06, 2012 - Chris Gupta

Democracy At Work? - PPM On Fluoride
Here is a commentary on the recent (Jan, 25th, 2011) Public Participation Meeting (PPM) on Fluoride in the City of London, Ontario. The meeting started with a strong pro fluoride stance form the City engineer. His lack of knowledge on chemistry of the toxic wastes used to fluoridate water could embarrass even a high school student never mind his own profession. He blatantly violated his "duty to public welfare" as... [read more]
January 29, 2012 - Chris Gupta

"Evidence Be Damned...Patient Outcome Is Irrelevant" - From Helke
Further to The Future of Complementary/Integrative Medicine & Patient Choice, here is an important must read and act note from Helke Ferrie, a superb Medical Science Writer and Publisher. Now that the true colours of the well known shortcomings of allopathic medicine are being discovered en mass, the screws are being tightened by the pharmaceutical masters on their medical puppets. It seems that they are prepared to stop at nothing.... [read more]
September 16, 2011 - Chris Gupta

 

 


Readers' Comments















Security code:




Please enter the security code displayed on the above grid


Due to our anti-spamming policy the comments you are posting will show up online within few hours from the posting time.



 

   

 

A Person Is Only As Valuable As She Can Be Of Help To Others

 

Creative Commons License
This work is licensed under a Creative Commons License.

These articles are brought to you strictly for educational and informational purposes.
Be sure to consult your health practitioner of choice prior to any specific use of any of the non drug device or food based medicinal products referenced herein.

 

875



Enter your Email


Preview | Powered by FeedBlitz


 

 


Most Popular Articles

Bad News About Statin Drugs

Cod Liver Oil - Number One Superfood

Statin Drugs & Memory Loss

Cold remedies that really work.- update

STATIN DRUGS Side Effects

 

 

Recent articles
Drinking Water Fluoridation is Genotoxic & Teratogenic

Democracy At Work? - PPM On Fluoride

"Evidence Be Damned...Patient Outcome Is Irrelevant" - From Helke

Why Remove Fluoride From Phosphate Rock To Make Fertilizer

FOFI Codex Meeting Report On Labelling May 9 - 13, 2011

Misconduct Of Health Canada Bureaucrats


Archive of all articles on this site

 

 


Most recent comments

Cold remedies that really work.- update

Why Doctors Don't Recommend More The Use Of Coq10?

Re: Dispelling the Night-Time Frequent Urination

Health via Meditation/Stress Reduction

Build a Low cost & simple Magnetic Pulser

 

 

Candida International

What Does MHRA Stand For??

Bono and Bush Party without Koch: AIDS Industry Makes a Mockery of Medical Science

Profit as Usual and to Hell with the Risks: Media Urge that Young Girls Receive Mandatory Cervical Cancer Vaccine

 

Health Supreme

Multiple sclerosis is Lyme disease: Anatomy of a cover-up

Chromotherapy in Cancer

Inclined Bed Therapy: Tilt your bed for healthful sleep

 

Evolving Collective Intelligence

Let Us Please Frame Collective Intelligence As Big As It Is

Reflections on the evolution of choice and collective intelligence

Whole System Learning and Evolution -- and the New Journalism

Gathering storms of unwanted change

Protect Sources or Not? - More Complex than It Seems

 

Consensus

Islanda, quando il popolo sconfigge l'economia globale.

Il Giorno Fuori dal Tempo, Il significato energetico del 25 luglio

Rinaldo Lampis: L'uso Cosciente delle Energie

Attivazione nei Colli Euganei (PD) della Piramide di Luce

Contatti con gli Abitanti Invisibili della Natura

 

Diary of a Knowledge Broker

Giving It Away, Making Money

Greenhouses That Change the World

Cycles of Communication and Collaboration

What Is an "Integrated Solution"?

Thoughts about Value-Add

 

Best sellers from